Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X
Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X.
Incannex Healthcare Inc. (NASDAQ: IXHL ) is one of the best strong buy penny stocks to invest in now . Incannex Healthcare Inc. (NASDAQ:IXHL) announced on June 25 the granting of a key patent by the United States Patent and Trademark Office (USPTO) titled "Compositions and Methods of Treatment for Obstructive Sleep Apnea." Management stated that the granted patent includes claims directed to the proprietary IHL-42X composition and its associated therapeutic methods to treat Obstructive Sleep Apnea (OSA), and added that the patent is anticipated to have a baseline expiry date of 9 July 2040. Incannex Healthcare Inc. (NASDAQ:IXHL) is in the process of exploring its eligibility for patent term extension following potential U.S. Food and Drug Administration (FDA) approval, with a goal of further bolstering the long-term exclusivity of the asset.
The company also stated that the grant of this patent marks a notable milestone in the advancement of IHL-42X and materially bolsters its intellectual property portfolio, supporting its lead clinical program. Incannex Healthcare Inc. (NASDAQ:IXHL) added that it is continuing to actively review data generated across the IHL-42X development program.
Incannex Healthcare Inc. (NASDAQ:IXHL) is a biotech company involved in the development of cannabinoid and psychedelic compound medicines. The company's focus is on the research and development of medicinal cannabis pharmaceutical products and psychedelic medicine therapies to treat a range of indications.
While we acknowledge the potential of IXHL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow .
Sinergia Empresarial continuará el seguimiento de esta información sobre incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X y ampliará la cobertura conforme se confirmen nuevos elementos relevantes para el ecosistema empresarial.
